Form FWP GSK plc Filed by: GSK plc

Go back to Form FWP GSK plc Filed by: GSK plc

GSK raises $6.5B in multi-tranche bond offering via US markets

September 9, 2026 6:22 AM EDT

GlaxoSmithKline Capital Inc., a subsidiary of GSK plc (NYSE: GSK), priced a multi-tranche bond offering totaling approximately $6.5 billion in aggregate principal amount, according to a press release statement.

The offering, traded September 8, 2026, with an expected settlement date of September 15, 2026, includes six tranches: $1.25 billion in 4.850% notes due... More